Stay updated on AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Sign up to get notified when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.

Latest updates to the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe ClinicalTrials.gov site revision displayed in the footer changed from v3.7.2 to v3.8.0.SummaryDifference0.0%

- Check26 days agoChange DetectedA site-wide NIH announcement was added, noting a transition from the term “Artificial Intelligence” to “Super Intelligence” and linking to transition updates and FAQs.SummaryDifference0.3%

- Check33 days agoChange DetectedThe site footer revision changes from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check40 days agoChange DetectedThe site revision label changes from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check60 days agoChange DetectedA new revision tag (Revision: v3.7.0) appears in the study history, indicating a UI/version update, while the previous tag (Revision: v3.6.6) is removed from the latest entry.SummaryDifference0.0%

- Check81 days agoChange DetectedThe Record History page displays Revision: v3.6.6, replacing the previous v3.6.5, indicating a new build of the page rendering.SummaryDifference0.0%

Stay in the know with updates to AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial
Enter your email address, and we'll notify you when there's something new on the AG-120 Combo vs Placebo with Azacitidine in AML Clinical Trial page.